For hver af disse indikationer er der påvist bedre virkning end af placebo på ændring fra grundlinieniveauet for total symptomscore (f. eks. hudkløe, erythem, nældefeber).
For each of these indications, superiority to placebo was demonstrated in the change from baseline of total symptom scores (e. g rhinitis symptom score) or disease symptoms and signs (e. g. skin itching, erythema, hives).